Literature DB >> 12918139

Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis.

Dao-Yong Liu1, Zhi-Hai Peng, Guo-Qiang Qiu, Chong-Zhi Zhou.   

Abstract

AIM: To study the expression and significance of telomerase activity and oxidative stress in hepatocellular carcinoma (HCC) with cirrhosis.
METHODS: In this study, TRAP-ELISA assay was used to determine telomerase activity in 21 cases of HCC as well as in 23 cases of hepatic cirrhosis. Malondialdehyde (MDA), glutathione S-transferase (GST) and total anti-oxidative capacity (T-AOC) were also examined in the same samples with human MDA, GST and T-AOC kits.
RESULTS: Eighteen of 21 cases of HCC were found to have increased telomerase activity, whereas only three of the 23 non-cancerous cirrhotic samples were found to have weak telomerase activity, and the difference was significant (P<0.001). No significant difference in telomerase activity was detected according to different tumor size, tumor stage, histological grade, HBsAg, contents of albumin, bilirubin, ALT, AFP, r-GT and platelet. There were significant differences between HCC and cirrhosis in the expression of MDA, GST and T-AOC respectively. Telomerase activity correlated positively with the content of MDA (P<0.05).
CONCLUSION: Telomerase activation is the early event of carcinogenesis, which is not correlated with clinicopathological factors of HCC. The dysfunction of the anti-oxidative system is closely correlated with the progression from cirrhosis to hepatocellular carcinoma. Oxidative stress may contribute partly to telomerase activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918139      PMCID: PMC4611562          DOI: 10.3748/wjg.v9.i8.1859

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  48 in total

Review 1.  Role of oxidative stress in telomere length regulation and replicative senescence.

Authors:  T von Zglinicki
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

Review 2.  Studies of the molecular mechanisms in the regulation of telomerase activity.

Authors:  J P Liu
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

3.  Cutting edge: antigen-dependent regulation of telomerase activity in murine T cells.

Authors:  K S Hathcock; N P Weng; R Merica; M K Jenkins; R Hodes
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

4.  Evidence for UV-associated activation of telomerase in human skin.

Authors:  M Ueda; A Ouhtit; T Bito; K Nakazawa; J Lübbe; M Ichihashi; H Yamasaki; H Nakazawa
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

Review 5.  Activation of telomerase in a human tumor.

Authors:  T de Lange
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).

Authors:  M Wick; D Zubov; G Hagen
Journal:  Gene       Date:  1999-05-17       Impact factor: 3.688

7.  Supression of telomerase activity in HL60 cells after treatment with differentiating agents.

Authors:  D Xu; A Gruber; C Peterson; P Pisa
Journal:  Leukemia       Date:  1996-08       Impact factor: 11.528

8.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

9.  Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation.

Authors:  O Hyeon Joo; M P Hande; P M Lansdorp; A T Natarajan
Journal:  Mutat Res       Date:  1998-06-05       Impact factor: 2.433

Review 10.  Telomeres, telomerase and cancer: is the magic bullet real?

Authors:  H W Sharma; J Y Maltese; X Zhu; H E Kaiser; R Narayanan
Journal:  Anticancer Res       Date:  1996 Jan-Feb       Impact factor: 2.480

View more
  7 in total

Review 1.  Pathophysiological basis for antioxidant therapy in chronic liver disease.

Authors:  Jesús Medina; Ricardo Moreno-Otero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.

Authors:  Mohammed A F Elewa; Mohammed M Al-Gayyar; Mona F Schaalan; Khaled H Abd El Galil; Mohamed A Ebrahim; Mamdouh M El-Shishtawy
Journal:  Clin Exp Metastasis       Date:  2015-05-22       Impact factor: 5.150

3.  Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma.

Authors:  Deng-Fu Yao; Wei Wu; Min Yao; Li-Wei Qiu; Xin-Hua Wu; Xiao-Qin Su; Li Zou; Deng-Bing Yao; Xian-Yong Meng
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

4.  Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells.

Authors:  Ahmad Shariftabrizi; Mohammad Reza Khorramizadeh; Farshid Saadat; Kamran Alimoghadam; Farnaz Safavifar; Mohammad Reza Ebrahimkhani
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

5.  Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response.

Authors:  O M Wolkowitz; S H Mellon; E S Epel; J Lin; V I Reus; R Rosser; H Burke; M Compagnone; J C Nelson; F S Dhabhar; E H Blackburn
Journal:  Mol Psychiatry       Date:  2011-01-18       Impact factor: 15.992

Review 6.  Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma.

Authors:  Po-Shuan Huang; Chia-Siu Wang; Chau-Ting Yeh; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

7.  Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.

Authors:  Romilda Cardin; Cardin Romilda; Marika Piciocchi; Piciocchi Marika; Alessandro Sinigaglia; Sinigaglia Alessandro; Enrico Lavezzo; Lavezzo Enrico; Marina Bortolami; Bortolami Marina; Andromachi Kotsafti; Kotsafti Andromachi; Umberto Cillo; Cillo Umberto; Giacomo Zanus; Zanus Giacomo; Claudia Mescoli; Mescoli Claudia; Massimo Rugge; Rugge Massimo; Fabio Farinati; Farinati Fabio
Journal:  BMC Cancer       Date:  2012-05-15       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.